UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 46,986,408
- Total 13F shares
- 38,225,503
- Share change
- +12,267,494
- Total reported value
- $641,423,803
- Put/Call ratio
- 102%
- Price per share
- $16.78
- Number of holders
- 114
- Value change
- +$207,327,873
- Number of buys
- 76
- Number of sells
- 38
Quarterly Holders Quick Answers
What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M96088105:
Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
6.9%
|
3,257,347
|
$48,860,205 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.6%
|
3,083,430
|
$46,251,450 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
5.6%
|
2,620,545
|
$39,308,175 | — | 31 Mar 2024 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
4.9%
|
2,303,031
|
$34,545,465 | — | 31 Mar 2024 | |
| Ran Nussbaum |
3/4/5
|
Director |
—
class O/S missing
|
1,485,168
|
$26,747,876 | — | 21 Oct 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
1,716,813
|
$25,752,195 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
3.5%
|
1,626,589
|
$24,398,835 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.8%
|
1,300,000
|
$19,500,000 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.6%
|
1,200,000
|
$18,000,000 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.4%
|
1,112,020
|
$16,680,300 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.8%
|
840,000
|
$12,600,000 | — | 31 Mar 2024 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
1.5%
|
686,472
|
$10,297,000 | — | 31 Mar 2024 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
|
Company |
1.4%
|
673,487
|
$10,102,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
536,994
|
$8,054,910 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
508,587
|
$7,628,805 | — | 31 Mar 2024 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
1.1%
|
495,606
|
$7,434,090 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.83%
|
390,549
|
$5,858,237 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
323,952
|
$4,859,280 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.61%
|
288,267
|
$4,324,005 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.57%
|
270,000
|
$4,050,000 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.57%
|
267,143
|
$4,008,000 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.53%
|
250,600
|
$3,759,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
232,500
|
$3,487,500 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.45%
|
212,280
|
$3,184,185 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.41%
|
194,966
|
$2,924,490 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.39%
|
184,184
|
$2,762,760 | — | 31 Mar 2024 | |
| ARK Investment Management LLC |
13F
|
Company |
0.31%
|
146,329
|
$2,194,935 | — | 31 Mar 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.31%
|
143,898
|
$2,158,470 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.29%
|
136,741
|
$2,051,115 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
113,862
|
$1,707,930 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.22%
|
104,100
|
$1,561,500 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
83,419
|
$1,251,285 | — | 31 Mar 2024 | |
| Annandale Capital, LLC |
13F
|
Company |
0.17%
|
81,552
|
$1,223,000 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.17%
|
80,497
|
$1,207,455 | — | 31 Mar 2024 | |
| De Lisle Partners LLP |
13F
|
Company |
0.16%
|
77,093
|
$1,153,696 | — | 31 Mar 2024 | |
| CIBC WORLD MARKETS CORP |
13F
|
Company |
0.16%
|
75,000
|
$1,125,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
71,816
|
$1,077,240 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.15%
|
70,952
|
$1,064,280 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.15%
|
70,406
|
$1,056,090 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
68,219
|
$1,023,285 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.13%
|
63,039
|
$945,585 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
62,880
|
$943,200 | — | 31 Mar 2024 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.13%
|
61,204
|
$918,060 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
53,063
|
$795,945 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.11%
|
52,954
|
$794,310 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.11%
|
49,790
|
$746,850 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
42,867
|
$643,005 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
42,262
|
$633,930 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
41,880
|
$628,200 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.08%
|
39,795
|
$596,925 | — | 31 Mar 2024 |
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q2 2024
As of 30 Jun 2024,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,225,503 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., GREAT POINT PARTNERS LLC, Point72 Asset Management, L.P., MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., COWEN AND COMPANY, LLC, MORGAN STANLEY, and Cormorant Asset Management, LP.
This page lists
114
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
111
Q2 2024 holders
114
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.